Timing of when Pfizer could approach Amarin is an interesting question....
What is the hold up now...?
By March of next year we are already looking at one year of exclusivity in Europe gone. One would think having years of exclusivity is important.....in essence the sooner this is in the hands of BP more value could be maximized.....but we are dealing with Amarin's management and BOD. Do they see the same thing.
Too bad we don't have an activist like Icahn to speak for shareholders.
News 
Market Data 
Discover 
